Entecavir 0.5 mg

DRUG6 trials

Sponsors

LG Life Sciences, Peking University First Hospital, Sun Yat-sen University, Ascentage Pharma Group Inc., First Affiliated Hospital of Zhejiang University

Conditions

Chronic Hep BChronic Hepatitis BCirrhosis, LiverHBVHepatitis BHepatocellular Carcinoma RecurrentLiver FibrosisMetagonimiasis

Phase 2

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

CompletedNCT01026610

LG Life SciencesChronic Hepatitis B

Start: 2009-08-31End: 2011-05-31Updated: 2012-10-05

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

LG Life SciencesChronic Hepatitis B

Start: 2010-08-31End: 2012-09-30Target: 115Updated: 2012-04-16

A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B

Ascentage Pharma Group Inc.Chronic Hep B, HBV, Hepatitis B

Start: 2020-06-03End: 2025-10-31Target: 122Updated: 2021-08-26

Phase 3

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Sun Yat-sen UniversityHepatocellular Carcinoma Recurrent

Start: 2019-07-25End: 2024-07-25Target: 706Updated: 2020-05-19

Phase 4

Synbiotics Interventions for Managing Cirrhosis and Its Complications

CompletedNCT05687409

First Affiliated Hospital of Zhejiang UniversityCirrhosis, Liver, Metagonimiasis

Start: 2019-11-24End: 2022-10-24Updated: 2023-01-18

Unknown Phase

A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers

Peking University First HospitalHepatitis B, Liver Fibrosis

Start: 2018-01-28End: 2021-09-30Target: 450Updated: 2018-06-27

Related Papers

Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment

Frontiers in Cellular and Infection Microbiology2023-06-165 citations

Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial

Frontiers in Microbiology2023-04-2610 citations